Outcomes of Carotid Revascularization in the Treatment of Restenosis After Prior Carotid Endarterectomy

Abstract

A retrospective analysis of the Vascular Quality Initiative database between September 2016 and April 2020. Of 4425 patients who had undergone ipsilateral carotid endarterectomy (CEA), 40% (1786) were treated by transfemoral carotid artery stenting (TF-CAS), 38% (1676) by transcarotid artery revascularization (TCAR), and 22% (963) by redo-CEA. TCAR was significantly associated with lower odds of in-hospital stroke, myocardial infarction (MI), and stroke, death, and MI when compared with redo-CEA. TCAR was associated with significantly lower odds of stroke and transient ischemic attack when compared with TF-CAS. TCAR was associated with a significantly lower odds of in-hospital stroke, MI, and stroke, death and MI when compared with redo-CEA and lower odds of in-hospital stroke and transient ischemic attack when compared with TF-CAS.